GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)
  136.60
  
   
    +5.94 
    (+4.55%)
   
  
  
  Streaming Delayed Price
  Updated:  1:46 PM EDT, Oct 28, 2025
  Add to My Watchlist
 
 
 All News about GeneDx Holdings Corp. - Class A Common Stock
From GeneDx
   Via Business Wire
   From GeneDx
   Via Business Wire
   
    GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
    
   October 20, 2025
   From GeneDx
   Via Business Wire
   
    GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
    
   October 14, 2025
   From GeneDx
   Via Business Wire
   From GeneDx
   Via Business Wire
   
    GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
    
   September 30, 2025
   From GeneDx
   Via Business Wire
   
    GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
    
   September 18, 2025
   From GeneDx
   Via Business Wire
   
    Seer Appoints Isaac Ro to its Board of Directors
    
   September 02, 2025
   From Seer, Inc.
   Via GlobeNewswire
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
